Previous 10 | Next 10 |
For nearly three months now, Wall Street and investors have had their resolve tested like never before due to the spread of the coronavirus disease 2019 (COVID-19). Although the stock market has rebounded quite a bit off of its lows, it doesn't overshadow the record-breaking volatility we witnes...
Quick Take Livongo Health ( LVGO ) went public in July 2019, pricing its shares at $28.00. The firm has developed a healthcare information system that assists patients in obtaining better outcomes in dealing with their chronic conditions. LVGO is very well positioned to benefit from a mo...
Shares of Livongo Health (NASDAQ: LVGO) were jumping 11.8% higher as of 3:05 p.m. EDT on Tuesday. The surge appeared to be the result of Jim Cramer highlighting the stock on CNBC's Mad Money on Monday. The boost from Cramer mentioning Livongo on his long-running TV show will likely b...
Biotech Pulse Source: COVID-19 image by Getty Images; edits by PrudentBiotech.com It has taken a pandemic for biotechs to take flight towards their all-time high. One of the first industry groups to recover from the virus-related selloff and be neutral for the year, biotech indexes hav...
For much of the past three months, investors have had their resolve tested like never before. The emergence and spread of the coronavirus disease 2019 (COVID-19) in the U.S. wound up leading to record-breaking volatility for the benchmark S&P 500 , and sent the index lower by a whopping 34%...
As I am making a start to this article on Livongo Health ( LVGO ) , I am kicking myself for having sold out too quickly on a promising business and stock. Great momentum has taken the stock far higher in such a short time period than I had foreseen among the possibilities just two months ago....
Despite the recent coronavirus-fueled market downturn -- and the economic consequences that will ensue -- some companies are poised to come out of the crisis stronger than ever, and their stock prices will continue to grow long after the crisis ends. That means now may still be a good time to co...
There are thousands of stocks on the market. Warren Buffett owns very few of them. Most of his fortune is tied up in Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) stock. And while Berkshire invests in publicly traded companies, its portfolio includes only around 40 stocks. Buffett doesn'...
Livongo Health (NASDAQ: LVGO) has made some investors a lot of money in a short period of time. The healthcare-technology provider conducted its initial public offering ( IPO ) in July 2019 with a price of $28 per share. An initial investment of $10,000 would have turned into around $19,000 ...
As the market crashed into bear territory this spring, Livongo Health (NASDAQ: LVGO) was on its way to a record high. And that's where the stock stands at the moment, up 115% this year. After this kind of performance, can we expect more from Livongo? Let's have a look. Image source: Li...
News, Short Squeeze, Breakout and More Instantly...
Would Teladoc (NYSE: TDOC) make a good fit for Berkshire (NYSE: BRK.A) (NYSE: BRK.B) ? In this clip from "The Rank" on Motley Fool Live , recorded on April 25 , Motley Fool contributor Zane Fracek makes the case for why he'd like to see Berkshire expand into heal...
Should You Buy These Health Care Stocks After Its Recent Dips? In the stock market today, investors appear to be cautious toward health care stocks as the COVID-19 vaccine roll-out gathers steam. While the pandemic has without a doubt place an enormous strain on the global healt...
Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO) , reported third-quarter earnings after the market close last Wednesday. While each company delivered more than 100% top-line growth, both stocks sold off on...